Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

STRASBOURG, France, March 29, 2023 (GLOBE NEWSWIRE) -- Biosynex SA ("Biosynex") (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project

Related Keywords

New York ,United States ,France ,Nevada ,Illkirch Graffenstaden ,Alsace ,French ,Gilles Broquelet ,Larry Abensur ,Chembio Diagnostics Inc ,Exchange Commission ,Nasdaq ,Merci Merger Sub Inc ,Securities Transfer Corporation ,Alliance Advisors ,Project Merci Merger Sub ,Chembio Diagnostics ,New York City ,Transfer Corporation ,Tender Offer Statement ,Information Agent ,Rapid Diagnostic Tests ,Recommendation Statement ,Quarterly Reports ,Annual Reports ,Diese Gold Aktie ,Sichern Sie ,Biosynex ,Xtends ,Fender ,Offer ,Hares ,Chembio ,Iagnostics ,